Jina Pharmaceuticals

Libertyville, United States Founded: 2007 • Age: 19 yrs
Develops nanotechnology-based drugs for treating cancer and infectious diseases.

About Jina Pharmaceuticals

Jina Pharmaceuticals is a Healthcare company based in Libertyville (United States) founded in 2007. It develops nanotechnology-based drugs for treating cancer and infectious diseases. It operates on a B2B model. Its focus areas include Pharmaceuticals, Drug Development and Nanotechnology. Its legal entity in India is Jina Pharmaceuticals Limited (U24233GJ2007PLC050155). Similar companies include C4 Therapeutics, Erasca and Revolution Medicines; 3 of its 3 listed similar companies have raised funding.

Company details

Jina Pharmaceuticals develops nanotechnology-based drugs for treating cancer and infectious diseases through providing healthcare solutions, producing pharmaceutical products, drug development, and nanotechnology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Indian entity net loss
    -₹8.4 Lakh

    FY 2021 · 0% margin

  • Indian entity EBITDA
    -₹8.4 Lakh

    FY 2021 · 0% margin

Board of directors of Jina Pharmaceuticals Limited. (Jina Pharmaceuticals)

Jina Pharmaceuticals Limited. is the primary company behind Jina Pharmaceuticals. The board of Jina Pharmaceuticals Limited. currently have 3 directors; the longest-serving is Bindi Binish Chudgar, appointed in 2007.

DirectorDesignationAppointedTenureEntity
Bindi Binish Chudgar
DIN 00080578
Director06 Mar 200719 yrs 8 moJina Pharmaceuticals Limited.
Imran Ehtiram Ali Ahmad
DIN 00546259
Director06 Mar 200719 yrs 8 moJina Pharmaceuticals Limited.
Binish Hasmukh Chudgar
DIN 00119503
Director06 Mar 200719 yrs 8 moJina Pharmaceuticals Limited.

Financials of Jina Pharmaceuticals

Figures of Jina Pharmaceuticals Limited., the primary company behind Jina Pharmaceuticals, for FY 2021. Net loss was -₹8.4 Lakh (0% margin). EBITDA was -₹8.4 Lakh (0% margin).

  • -₹8.4 LakhNet loss · 0% margin
  • -₹8.4 LakhEBITDA · 0% margin
  • ₹6.3 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Jina Pharmaceuticals Limited. are on its company page.

Premium access

Detailed financial statements for Jina Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Jina Pharmaceuticals

Jina Pharmaceuticals has 3 listed similar companies in our database, 3 of them funded. They include C4 Therapeutics, Erasca and Revolution Medicines.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
c4therapeutics.com2016Cambridge, United States$223M121
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
erasca.com2018San Diego, United States$300M120
Small molecule therapeutics for cancer treatment are developed.
revmed.com2014Redwood, United States$326.29M181
Cancer therapies are developed using selective pathway inhibitors.
Premium access

Detailed similar companies of Jina Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as Jina Pharmaceuticals (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Jina Pharmaceuticals

Jina Pharmaceuticals was founded in 2007.

Jina Pharmaceuticals is headquartered in Libertyville, United States. It is registered at Libertyville, Illinois, United States.

Jina Pharmaceuticals develops nanotechnology-based drugs for treating cancer and infectious diseases through providing healthcare solutions, producing pharmaceutical products, drug development, and nanotechnology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Jina Pharmaceuticals's top competitors include C4 Therapeutics, Erasca and Revolution Medicines.

Jina Pharmaceuticals operates through Jina Pharmaceuticals Limited..

The legal entities of Jina Pharmaceuticals currently have 3 directors, including Bindi Binish Chudgar, Imran Ehtiram Ali Ahmad, Binish Hasmukh Chudgar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available